| For: | Ma DX, Ding XP, Zhang C, Shi P. Combined targeted therapy and immunotherapy in anaplastic thyroid carcinoma with distant metastasis: A case report. World J Clin Cases 2022; 10(12): 3849-3855 [PMID: 35647147 DOI: 10.12998/wjcc.v10.i12.3849] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i12/3849.htm |
| Number | Citing Articles |
| 1 |
Kang Ning, Qiaorong Chen, Yu Guo, Hao Li, Bu Zou, Taonong Cai, Li Wang, Yongchao Yu, Zhenyu Luo, Jian Bu, Han Hong, Ziying Li, Xujia Wen, Mingjie Jiang, Tong Wu, Tianrun Liu, Weichao Chen, Zan Jiao, Ankui Yang. Efficacy and safety of immunotherapy in anaplastic thyroid carcinoma: a systematic review and meta-analysis. International Journal of Surgery 2026; 112(1): 1708 doi: 10.1097/JS9.0000000000003301
|
| 2 |
Qiushi Jia, Fulin Li, Chunxiang Li, Changzhi Guo, Shuang Wu, Liguo Hao, Zhongyuan Li. Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer. Drug Delivery and Translational Research 2025; 15(6): 2099 doi: 10.1007/s13346-024-01727-2
|
| 3 |
Lingyan Zhou, Shujian Xu, Yuwen Song, Dongqing Jiang, Shihong Chen, Avaniyapuram Kannan Murugan. Influence of the tumor microenvironment on genetic mutations in thyroid carcinoma. PLOS One 2026; 21(2): e0341123 doi: 10.1371/journal.pone.0341123
|
| 4 |
Xinyu Ying, Xinyi Ma, Ziru Yang, Bo Zhou. Th9 Cytokines Inhibit Proliferation, Promote Apoptosis, and Immune Escape in Thyroid Carcinoma Cells. Applied Biochemistry and Biotechnology 2024; 196(9): 6189 doi: 10.1007/s12010-023-04821-2
|
| 5 |
|
| 6 |
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, Ryosuke Sato, Takahiro Inoue, Takumi Kumai, Miki Takahara. Harnessing Immunity to Treat Advanced Thyroid Cancer. Vaccines 2023; 12(1): 45 doi: 10.3390/vaccines12010045
|
